Morgan Stanley
LUNG icon

Morgan Stanley’s Pulmonx LUNG Stock Holding History

Morgan Stanley’s Portfolio LUNG Stock Details LUNG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.8M Sell
2,922,921
-1,070,641
-27% -$1.47M ﹤0.01% 4421
2026
Q1 		$5.15M Sell
3,993,562
-166,907
-4% -$276K ﹤0.01% 4116
2025
Q4 		$9.19M Buy
4,160,469
+539,793
+15% +$1.01M ﹤0.01% 3681
2025
Q3 		$5.87M Buy
3,620,676
+63,628
+2% +$133K ﹤0.01% 4018
2025
Q2 		$9.21M Buy
3,557,048
+62,919
+2% +$248K ﹤0.01% 3515
2025
Q1 		$23.5M Buy
3,494,129
+421,291
+14% +$2.98M ﹤0.01% 2531
2024
Q4 		$20.9M Sell
3,072,838
-716,107
-19% -$4.72M ﹤0.01% 2704
2024
Q3 		$31.4M Buy
3,788,945
+317,868
+9% +$2.3M ﹤0.01% 2318
2024
Q2 		$22M Buy
3,471,077
+819,632
+31% +$6.3M ﹤0.01% 2557
2024
Q1 		$24.6M Buy
2,651,445
+372,724
+16% +$4.37M ﹤0.01% 2473
2023
Q4 		$29.1M Buy
2,278,721
+58,895
+3% +$614K ﹤0.01% 2282
2023
Q3 		$22.9M Buy
2,219,826
+246,302
+12% +$2.85M ﹤0.01% 2309
2023
Q2 		$25.9M Sell
1,973,524
-640,847
-25% -$7.84M ﹤0.01% 2207
2023
Q1 		$29.2M Buy
2,614,371
+463,866
+22% +$4.58M ﹤0.01% 2035
2022
Q4 		$18.1M Buy
2,150,505
+296,682
+16% +$2.82M ﹤0.01% 2441
2022
Q3 		$30.9M Sell
1,853,823
-273,948
-13% -$5.04M ﹤0.01% 1743
2022
Q2 		$31.3M Buy
2,127,771
+1,897,698
+825% +$39.1M ﹤0.01% 1796
2022
Q1 		$5.71M Buy
230,073
+163,024
+243% +$4.21M ﹤0.01% 3545
2021
Q4 		$2.15M Buy
67,049
+48,171
+255% +$1.76M ﹤0.01% 4527
2021
Q3 		$680K Sell
18,878
-46,158
-71% -$1.82M ﹤0.01% 5311
2021
Q2 		$2.87M Buy
65,036
+20,533
+46% +$894K ﹤0.01% 4325
2021
Q1 		$2.04M Buy
44,503
+30,316
+214% +$1.74M ﹤0.01% 4246
2020
Q4 		$979K Buy
+14,187
New +$695K ﹤0.01% 4684

Other funds holding LUNG

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ECM
ExodusPoint Capital Management New York $15.5B AUM 38.81% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $417M AUM 22.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Morgan Stanley's LUNG Position: Q2 2026 in Review

Morgan Stanley reduced its Pulmonx (LUNG) stake by 27% in Q2 2026, selling an estimated $1.47M and leaving 2,922,921 shares worth $3.8M. The position accounts for ﹤0.01% of the portfolio, ranked #4421.

Morgan Stanley first reported a position in LUNG in Q4 2020 and has held it in 23 quarters since. The position peaked at $31.4M in Q3 2024. 107 funds tracked by Wall St. Rank hold LUNG as of Q2 2026.

  • Morgan Stanley held 2,922,921 shares of Pulmonx worth $3.8M as of Q2 2026.
  • Morgan Stanley sold 1,070,641 Pulmonx shares in Q2 2026, an estimated $1.47M.
  • Pulmonx made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #4421 holding.
  • Morgan Stanley first reported a position in Pulmonx in Q4 2020 and has held it in 23 quarters since.
  • Morgan Stanley's Pulmonx position peaked at $31.4M in Q3 2024.
  • 107 funds tracked by Wall St. Rank held Pulmonx as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.